---
schema_version: "secwatch.filing_event.v1"
accession: "0001453687-23-000061"
form_type: "8-K"
ticker: "RNAC"
cik: "0001453687"
company_name: "Cartesian Therapeutics, Inc."
filed_at: "2023-09-13T23:59:59+00:00"
generated_at: "2026-06-10T18:58:52.567731+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "low"
source: SEC EDGAR
---

# Selecta Biosciences fully repays debt under loan agreement with Oxford Finance and Silicon Valley Bank

## Summary
- Paid all outstanding amounts under Loan and Security Agreement dated Aug 31, 2020 (as amended).
- Accrued interest and prepayment penalty included; all obligations discharged in full.
- All unfunded commitments terminated; liens and security interests automatically released.
- Warrants previously issued to Oxford and Silicon Valley Bank remain outstanding.
- No financial amounts disclosed; company no longer has debt obligations under this agreement.

## SEC filing metadata
- accession: 0001453687-23-000061
- form_type: 8-K
- ticker: RNAC
- cik: 0001453687
- company_name: Cartesian Therapeutics, Inc.
- filed_at: 2023-09-13T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: low
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453687/000145368723000061/0001453687-23-000061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453687/000145368723000061/selb-20230911.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001453687-23-000061
- JSON: https://secwatch.observer/filing/0001453687-23-000061.json
- Plain text: https://secwatch.observer/filing/0001453687-23-000061.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.